Immunohistochemical analysis of the two MCC tumors carrying activating PIK3CA mutations demonstrated a strong AKT phosphorylation; this observation is in line with the fact that these mutations contribute to an activation of the PI3K/AKT signaling pathway. This evidence concerns the gene AKT1 and Merkel cell skin cancer.